YANG Qi-Zhou, FU-Rui, WANG Li-Li, XIANG Si-Jing, GAO Feng-Lian, ZHANG Li-Xia. Clinical Features and Etiological Analysis of Acute Cerebral Infarction in Prostate Cancer Patients[J]. Chinese Journal of Stroke, 2021, 16(02): 141-146.
[1] LIAN Z P,XIE Y K,LU Y X,et al. Trends in themajor causes of death in China,1982-2010[J]. ChinMed J(Engl),2014,127(4):777-781.[2] CHEN P C,MUO C H,LEE Y T,et al. Lung cancerand incidence of stroke:a population-based cohortstudy[J]. Stroke,2011,42(11):3034-3039.[3] TORRE L A,BRAY F,SIEGEL R L,et al. Globalcancer statistics,2012[J]. CA Cancer J Clin,2015,65(2):87-108.[4] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682.[5] HEIDENREICH A,BASTIAN P J,BELLMLMTJ A,et a1. EAU guidelines on prostate cancer. part1:screening,diagnosis,and local treatment withcurative intent-update 2013[J]. Eur Urol,2014,65(1):124-137.[6] KIM J M,JUNG K H,PARK K H,et a1. Clinicalmanifestation of cancer related stroke:retrospectivecase-control study[J]. J Neurooncol,2013,111(3):295-301.[7] NGUYEN T,DEANGELIS L M. Stroke in cancerpatients[J]. Curr Neurol Neurosci Rep,2006,6(3):187-192.[8] SANOSSIAN N,DJABIRAS C,MACK W J,eta1. Trends in cancer diagnoses among inpatientshospitalized with stroke[J]. J Stroke Cerebrovasc Dis,2013,22(7):1146-1150.[9] CHEN Y,QIN Q X,QIN C,et al. Specificbiomarkers of prostate cancer-associated ischemicstroke:a case-control study[J]. Med Sci Monit,2019,25(7):5536-5542.[10] SCHWARZBACH C J,SCHAEFER A,EBERTA,et a1. The importance of cancer-associatedhypercoagulation as a possible stroke etiology[J].Stroke,2012,43(11):3029-3034.[11] ZÖLLER B,JI J,SUNDQUIST J,et al. Risk ofhaemorrhagic and ischaemic stroke in patients with cancer:a nationwide follow-up study fromSweden[J]. Eur J Cancer,2012,48(12):1875-1883.[12] DARDIOTIS E,ALOIZOU A M,MARKOULAS,et al. Cancer-associated stroke:pathophysiology,detection and management(review)[J]. Int J Oncol,2019,54(3):779-796.[13] FALANGA A,RUSSO L,MILESI V,et al.Mechanisms and risk factors of thrombosis incancer[J]. Crit Rev Oncol Hematol,2017,118(10):79-83.[14] SEOK J M,KIM S G,KIM J W,et al. Coagulopathyand embolic signal in cancer patients with ischemicstroke[J]. Ann Neurol,2010,68(2):213-219.[15] KONO T,OHTSUKI T,HOSOMI N,et al. Cancerassociatedischemic stroke is associated withelevated D-dimer and fibrin degradation productlevels in acute ischemic stroke with advancedcancer[J]. Geriatr Gerontol Int,2012,12(3):468-474.[16] KIM K,LEE J H. Risk factors and biomarkers ofischemic stroke in cancer patients[J]. J Stroke,2014,16(2):91-96.[17] TAE B S,JEON B J,CHOI H,et al. Is androgendeprivation therapy associated with cerebralinfarction in patients with prostate cancer? A Koreannationwide population-based propensity scorematching study[J]. Cancer Medicine,2019,8(9):4475-4483.[18] JESPERSEN C G,NØRGAARD M,BORREM. Androgen-deprivation therapy in treatment ofprostate cancer and risk of myocardial infarction andstroke:a nationwide Danish population-based cohortstudy[J]. Eur Urol,2014,65(4):704-709.[19] 阙娴婷,秦超,梁志坚,等. 前列腺癌相关脑梗死的发病特点[J]. 卒中与神经疾病,2018,25(2):155-162.
[J]. Chinese Journal of Stroke, 2024, 19(8): 924-930.
[12]
LU Dan, CHEN Weiqi, WANG Yaping, DUAN Wanying, GUO Lei, WANG Ling, LIU Liping, XU Anding, WANG Yongjun, Cerebroprotection Academic Roundtable Academic Committee of Chinese Stroke Association .